After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, BMY falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Bristol-Myers Squibb Co is $100.12B. A total of 11.76 million shares were traded on the day, compared to an average of 15.57M shares.
In the most recent transaction, Elkins David V sold 56,000 shares of BMY for 47.33 per share on Sep 02 ’25. After the transaction, the EVP, Chief Financial Officer now owns 167,379 company shares. In a previous transaction on Sep 02 ’25, Elkins David V bought 56,000 shares at 47.30 per share.
Among the insiders who sold shares, Short Bartie Wendy disposed of 378 shares on Aug 02 ’25 at a per-share price of $44.23. This resulted in the EVP, Corporate Affairs holding 5,066 shares of BMY after the transaction. In another insider transaction, Hickey Benjamin sold 97 shares at $38.01 per share on May 09 ’25. Company shares held by the President, RayzeBio Org. now total 0.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Bristol-Myers Squibb Co pays an annual dividend of $2.48, resulting in a dividend yield of 5.04%, and it has a price to earnings (P/E) ratio of 16.61.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BMY has a high of $63.33 and a low of $42.52.
As of this writing, BMY has an earnings estimate of $1.65 per share for the current quarter. EPS was calculated based on a consensus of 17.0 estimates, with a high estimate of $1.8 per share and a lower estimate of $1.51. The company reported an EPS of $1.67 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $9.11, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.38.
